ESC 365 - Management of the catecholaminergic polymorphic ventricular tachycardia patient not protected by beta blockers

EHRA Premium Access

Management of the catecholaminergic polymorphic ventricular tachycardia patient not protected by beta blockers

Session: Implication of basic insights for management of channelopathies

Topic: Myocardial Disease

Speaker: Doctor I. Denjoy (Paris, FR)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Doctor Isabelle Denjoy

Hospital Bichat-Claude Bernard, Paris (France)

4 presentations

0 follower

3 more presentations in this session

Interpretation of variants of unknown significance

Speaker: Professor C. Bezzina (Amsterdam, NL)

Precision medicine in long QT syndrome

Speaker: Professor P. Schwartz (Cusano Milanino, IT)

Risk stratification in Brugada syndrome

Speaker: Professor S. Viskin (Tel Aviv, IL)

Access the full session

Implication of basic insights for management of channelopathies

Speakers: Doctor I. Denjoy, Professor C. Bezzina, Professor P. Schwartz, Professor S. Viskin

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources